Quallent Pharmaceuticals Health

Quallent Pharmaceuticals is a private-label pharmaceutical company and a subsidiary of Evernorth Health Services, a division of The Cigna Group. Founded in 2021, the company focuses on providing high-quality, affordable generic medications and biosimilars to help lower the total cost of care for patients and payers. Quallent operates by partnering with global manufacturers to source and distribute a wide range of products, including oral solids and complex biologics. A key component of its strategy is the launch of biosimilars, such as adalimumab, to compete in high-cost specialty drug categories. By leveraging Evernorth's extensive distribution network and clinical expertise, Quallent aims to ensure a stable and cost-effective supply of essential medicines.